Jan 9, 2014
Adimab Announces New Partnerships with Jounce, Five Prime, and Alector
'Adimab is focused on partnering with the best drug developers in the world, whether they are major pharmaceutical companies or smaller biotech companies,' said , Co-Founder and Chief Executive Officer of Adimab.
Adimab Continues Roll-out of Its Technology Transfer Program with...
Adimab, LLC, a leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced its 3rd technology transfer, by licensing the Adimab technology to Novo Nordisk.
Arsanis Inc Closes $20 Million Series B Financing
Arsanis Inc, a privately-held biotechnology company developing human monoclonal antibodies for severe infectious diseases, today announced that it has raised $20 million in a Series B financing.